Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

IMMUNITYBIO, INC. (IBRX)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 5
  • 1 comments

ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting

Market reaction Comment Full text

NORTHERN POTASH CO. (NPTH)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 5
  • 1 comments

NEUPATH HEALTH TO REPORT Q1 2026 RESULTS AND HOST INVESTOR WEBINAR

Market reaction Comment Full text

TELESAT CORP (TSAT)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 6
  • 1 comments

Telesat reports results for the quarter ended March 31, 2026

Market reaction Comment Full text

FIRST SEACOAST BANCORP, INC. (FSEA)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 4
  • 1 comments

Cambridge Financial Group, Inc. and First Seacoast Bancorp, Inc. Agree to Merge

Market reaction Comment Full text

AGCO CORP /DE (AGCO)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 4
  • 1 comments

AGCO REPORTS FIRST-QUARTER RESULTS

Market reaction Comment Full text

CUMMINS INC (CMI)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 4
  • 1 comments

Cummins Delivered Strong Operating Results and Returned $519 Million to Shareholders in the First Quarter of 2026; Raises Full-year Outlook

Market reaction Comment Full text

FORTIVE CORP (FTV)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 6
  • 1 comments

Fortive To Present at 2026 Wolfe Research 19th Annual Global Transportation & Industrials Conference

Market reaction Comment Full text

KURA ONCOLOGY, INC. (KURA)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 5
  • 1 comments

Kura Oncology to Report First Quarter 2026 Financial Results

Market reaction Comment Full text

CYTOKINETICS INC (CYTK)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 3
  • 1 comments

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Market reaction Comment Full text

VSE CORP (VSEC)

  • Business News
  • May 05, 2026, 11:30 UTC
  • 3
  • 1 comments

VSE Corporation Completes Acquisition of Precision Aviation Group

Market reaction Comment Full text
  • Previous
  • 394
  • 395
  • 396
  • 397
  • 398
  • Next

Search

News categories

  • Technical Exchange News(12397)
  • Event(6229)
  • SEC News(274384)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158867)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin